Dana Yaacov-garbeli - Net Worth and Insider Trading

Dana Yaacov-garbeli Net Worth

The estimated net worth of Dana Yaacov-garbeli is at least $97,318 dollars as of 2024-11-09. Dana Yaacov-garbeli is the CFO of Entera Bio Ltd and owns about 56,580 shares of Entera Bio Ltd (ENTX) stock worth over $97,318. Details can be seen in Dana Yaacov-garbeli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dana Yaacov-garbeli has not made any transactions after 2022-11-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Dana Yaacov-garbeli

To

Dana Yaacov-garbeli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dana Yaacov-garbeli owns 1 companies in total, including Entera Bio Ltd (ENTX) .

Click here to see the complete history of Dana Yaacov-garbeli’s form 4 insider trades.

Insider Ownership Summary of Dana Yaacov-garbeli

Ticker Comapny Transaction Date Type of Owner
ENTX Entera Bio Ltd 2022-11-14 Israel CFO

Dana Yaacov-garbeli Latest Holdings Summary

Dana Yaacov-garbeli currently owns a total of 1 stock. Dana Yaacov-garbeli owns 56,580 shares of Entera Bio Ltd (ENTX) as of November 14, 2022, with a value of $97,318.

Latest Holdings of Dana Yaacov-garbeli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENTX Entera Bio Ltd 2022-11-14 56,580 1.72 97,318

Holding Weightings of Dana Yaacov-garbeli


Dana Yaacov-garbeli Form 4 Trading Tracker

According to the SEC Form 4 filings, Dana Yaacov-garbeli has made a total of 1 transactions in Entera Bio Ltd (ENTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entera Bio Ltd is the acquisition of 56,580 shares on November 14, 2022, which cost Dana Yaacov-garbeli around $29,987.

Insider Trading History of Dana Yaacov-garbeli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dana Yaacov-garbeli Trading Performance

GuruFocus tracks the stock performance after each of Dana Yaacov-garbeli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dana Yaacov-garbeli is 51.8%. GuruFocus also compares Dana Yaacov-garbeli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dana Yaacov-garbeli within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dana Yaacov-garbeli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dana Yaacov-garbeli

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 11.91 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.95 LIMIT LIMIT LIMIT LIMIT LIMIT

Dana Yaacov-garbeli Ownership Network

Ownership Network List of Dana Yaacov-garbeli

No Data

Ownership Network Relation of Dana Yaacov-garbeli

Insider Network Chart

Dana Yaacov-garbeli Owned Company Details

What does Entera Bio Ltd do?

Who are the key executives at Entera Bio Ltd?

Dana Yaacov-garbeli is the Israel CFO of Entera Bio Ltd. Other key executives at Entera Bio Ltd include director & President of R&D Phillip Schwartz , U.S.based CFO Ramesh Ratan , and director & Chief Executive Officer Spiros Jamas .

Entera Bio Ltd (ENTX) Insider Trades Summary

Over the past 18 months, Dana Yaacov-garbeli made no insider transaction in Entera Bio Ltd (ENTX). Other recent insider transactions involving Entera Bio Ltd (ENTX) include a net purchase of 35,115 shares made by Haya Taitel , a net purchase of 43,952 shares made by Gerald M Lieberman , and a net purchase of 40,000 shares made by Sean Ellis .

In summary, during the past 3 months, insiders sold 0 shares of Entera Bio Ltd (ENTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Entera Bio Ltd (ENTX) were sold and 143,019 shares were bought by its insiders, resulting in a net purchase of 143,019 shares.

Entera Bio Ltd (ENTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Entera Bio Ltd Insider Transactions

No Available Data

Dana Yaacov-garbeli Mailing Address

Above is the net worth, insider trading, and ownership report for Dana Yaacov-garbeli. You might contact Dana Yaacov-garbeli via mailing address: Kiryat Hadassah, Minrav Building, Fifth Floor, Jerusalem L3 9112002.